| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Stock | 117K | $656K | $5.61 | May 20, 2024 | Direct |
| Beyond Air, Inc. | Director | Common Stock | 43.6K | $17.3K | $0.40 | Aug 14, 2024 | Direct |
| Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 106K | Mar 2, 2024 | Direct | ||
| Bone Biologics Corp | Director | Non-Employee Stock Option | 85.8K | Sep 18, 2023 | Direct | ||
| Beyond Air, Inc. | Director | Stock Option (right to buy) | 45K | Mar 20, 2024 | Direct | ||
| Beyond Air, Inc. | Director | Stock Options (Right to buy) | 25K | Nov 22, 2024 | Direct | ||
| SAB Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 20K | Jul 15, 2024 | Direct | ||
| AVEO PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Jan 19, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XAIR | Beyond Air, Inc. | Nov 22, 2024 | 14 | $0 | 4 | Nov 26, 2024 | Director |
| XAIR | Beyond Air, Inc. | Aug 14, 2024 | 1 | $15.6K | 4 | Aug 15, 2024 | Director |
| SABS | SAB Biotherapeutics, Inc. | Jul 15, 2024 | 1 | $0 | 4 | Jul 17, 2024 | Director |
| EDIT | Editas Medicine, Inc. | May 20, 2024 | 1 | -$125K | 4 | May 22, 2024 | EVP, CHIEF FINANCIAL OFFICER |
| XAIR | Beyond Air, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director |
| EDIT | Editas Medicine, Inc. | Mar 2, 2024 | 3 | $0 | 4 | Mar 5, 2024 | EVP, CHIEF FINANCIAL OFFICER |
| BBLG | Bone Biologics Corp | Sep 18, 2023 | 1 | $0 | 4 | Sep 20, 2023 | Director |
| EDIT | Editas Medicine, Inc. | May 17, 2023 | 2 | $0 | 4 | May 18, 2023 | EVP, CHIEF FINANCIAL OFFICER |
| EDIT | Editas Medicine, Inc. | May 17, 2023 | 0 | $0 | 3 | May 18, 2023 | EVP, CHIEF FINANCIAL OFFICER |
| SABS | SAB Biotherapeutics, Inc. | Apr 3, 2023 | 1 | $0 | 4 | Apr 5, 2023 | Director |
| SABS | SAB Biotherapeutics, Inc. | Apr 3, 2023 | 0 | $0 | 3 | Apr 5, 2023 | Director |
| XAIR | Beyond Air, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
| XAIR | Beyond Air, Inc. | Mar 16, 2023 | 1 | $13.6K | 4 | Mar 20, 2023 | Director |
| AVEO | AVEO PHARMACEUTICALS, INC. | Jan 19, 2023 | 3 | $0 | 4 | Jan 19, 2023 | Chief Financial Officer |
| BBLG | Bone Biologics Corp | Aug 23, 2022 | 1 | $0 | 4 | Mar 8, 2023 | Director |
| XAIR | Beyond Air, Inc. | Mar 3, 2022 | 1 | $0 | 4 | Mar 7, 2022 | Director |
| AVEO | AVEO PHARMACEUTICALS, INC. | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | Chief Financial Officer |
| BBLG | Bone Biologics Corp | Oct 26, 2021 | 2 | $0 | 4 | Feb 28, 2022 | Director |
| BBLG | Bone Biologics Corp | Oct 15, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Director |